Actinomycotic Osteomyelitis of the Maxilla in a Patient on Phenytoin

Actinomycosis is caused by Actinomyces species and is relatively rare in humans. Because of the special collateral blood flow, osteomyelitis is less common in the maxilla than the mandible. Although there are few case reports for jaw osteomyelitis, actinomycotic osteomyelitis associated with phenyto...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in dentistry 2022, Vol.19
Main Authors: Aghahosseini, Farzaneh, Ghasemzadeh Hoseini, Elaheh, Mahdavi, Nazanin
Format: Article
Language:English
Subjects:
Actinomyces
Osteomyelitis
Maxilla
Phenytoin
Immune System
Actinomycosis
Antiepileptic agents
Biopsy
Blood flow
Case Report
Case reports
Dentistry
Disease
Immune system
Immunosuppressive agents
Infections
Jaw
Ligaments
Maxilla
Osteomyelitis
Phenytoin
Rare species
Teeth
Tomography
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Actinomycosis is caused by Actinomyces species and is relatively rare in humans. Because of the special collateral blood flow, osteomyelitis is less common in the maxilla than the mandible. Although there are few case reports for jaw osteomyelitis, actinomycotic osteomyelitis associated with phenytoin therapy has not been reported before. The data show that antiepileptic drugs induce suppression of the immune system. This report presents a rare case of a 58-year-old man on phenytoin with actinomycotic osteomyelitis, and reviews the relevant literature.
ISSN:2676-296X
2676-296X
DOI:10.18502/fid.v19i3.8511